Answers are grounded in this paper and cite their sources.
Aim To describe clinical isolates of Mycobacterium tuberculosis harboring the silent Phe433Phe mutation in the rpoB gene in Paraná State, Brazil, and to evaluate its role in diagnostic discordance and molecular surveillance.Methods This study analyzed M. tuberculosis isolates processed at the Central Public Health Laboratory of Paraná between 2021 and 2023 showing discordant rifampicin resistance results between a molecular diagnostics assays line probe assay (LPA; GenoType MTBDRplus v2.0) and a rapid molecular test (GeneXpert® MTB/RIF Ultra). Phenotypic drug susceptibility testing was performed using an automated mycobacterial growth indicator tube system (BACTEC™ MGIT™ 960). Whole-genome sequencing was used to confirm mutations and assess genomic clustering.Results Among 3,351 isolates analyzed by LPA, 80 were classified as rifampicin-resistant by LPA, of which 31 (38.7%) exhibited an inferred mutation in the rpoB wt3 region while remaining susceptible according to rapid molecular testing and phenotypic assays. Most cases were concentrated in the 17th Health Region (71.0%), including individuals deprived of liberty (25.8%). Whole-genome sequencing of 22 viable isolates confirmed the silent Phe433Phe mutation. Genomic analysis identified clustered isolates compatible with recent transmission, particularly within prison-related settings.Conclusion The silent Phe433Phe mutation is a potential epidemiological marker and a source of diagnostic discordance. Integrating molecular and genomic approaches is essential for tuberculosis surveillance.
No takes yet. Share an insight, caveat, or question.
Shibata et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: